Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience

Patients with locally advanced cervical cancer (LACC) are at risk of para-aortic lymph node (PALN) metastasis. Pelvic concurrent chemoradiotherapy, the current standard treatment for LACC, has a PALN failure rate of 9% according to the Radiation Therapy Oncology Group Trial 90–01, suggesting that it...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jie, Lin, Jhen-Bin, Sun, Fang-Ju, Chen, Yu-Jen, Chang, Chih-Long, Jan, Ya-Ting, Wu, Meng-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348152/
https://www.ncbi.nlm.nih.gov/pubmed/28272204
http://dx.doi.org/10.1097/MD.0000000000006158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348152/
https://www.ncbi.nlm.nih.gov/pubmed/28272204
http://dx.doi.org/10.1097/MD.0000000000006158

Ejemplares similares